These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7528253)

  • 1. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
    Pagano PJ; Chong KT
    J Infect Dis; 1995 Jan; 171(1):61-7. PubMed ID: 7528253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.
    Chong KT; Pagano PJ; Hinshaw RR
    Antimicrob Agents Chemother; 1994 Feb; 38(2):288-93. PubMed ID: 7514857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
    Dueweke TJ; Poppe SM; Romero DL; Swaney SM; So AG; Downey KM; Althaus IW; Reusser F; Busso M; Resnick L
    Antimicrob Agents Chemother; 1993 May; 37(5):1127-31. PubMed ID: 7685995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
    Peterson PK; Gekker G; Hu S; Chao CC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2465-8. PubMed ID: 7530933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.
    Poppe SM; Slade DE; Chong KT; Hinshaw RR; Pagano PJ; Markowitz M; Ho DD; Mo H; Gorman RR; Dueweke TJ; Thaisrivongs S; Tarpley WG
    Antimicrob Agents Chemother; 1997 May; 41(5):1058-63. PubMed ID: 9145869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous mutations at Tyr-181 and Tyr-188 in HIV-1 reverse transcriptase prevents inhibition of RNA-dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U-90152s.
    Fan N; Rank KB; Evans DB; Thomas RC; Tarpley WG; Sharma SK
    FEBS Lett; 1995 Aug; 370(1-2):59-62. PubMed ID: 7544302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.
    Freimuth WW
    Adv Exp Med Biol; 1996; 394():279-89. PubMed ID: 8815692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
    Campbell TB; Young RK; Eron JJ; D'Aquila RT; Tarpley WG; Kuritzkes DR
    J Infect Dis; 1993 Aug; 168(2):318-26. PubMed ID: 7687641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine.
    Chong KT; Pagano PJ
    Antiviral Res; 1997 Mar; 34(1):51-63. PubMed ID: 9107385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
    Koup RA; Brewster F; Grob P; Sullivan JL
    AIDS; 1993 Sep; 7(9):1181-4. PubMed ID: 7692883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Okamoto M; Okamoto T; Baba M
    Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).
    Balzarini J; Pérez-Pérez MJ; Vélazquez S; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5470-4. PubMed ID: 7539917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors.
    Nottet HS; Oteman MH; Visser MR; Verhoef J
    J Antimicrob Chemother; 1994 Feb; 33(2):366-8. PubMed ID: 7514164
    [No Abstract]   [Full Text] [Related]  

  • 14. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
    Bacheler L; Jeffrey S; Hanna G; D'Aquila R; Wallace L; Logue K; Cordova B; Hertogs K; Larder B; Buckery R; Baker D; Gallagher K; Scarnati H; Tritch R; Rizzo C
    J Virol; 2001 Jun; 75(11):4999-5008. PubMed ID: 11333879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
    Fan N; Evans DB; Rank KB; Thomas RC; Tarpley WG; Sharma SK
    FEBS Lett; 1995 Feb; 359(2-3):233-8. PubMed ID: 7532595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors.
    Vasudevachari MB; Battista C; Lane HC; Psallidopoulos MC; Zhao B; Cook J; Palmer JR; Romero DL; Tarpley WG; Salzman NP
    Virology; 1992 Sep; 190(1):269-77. PubMed ID: 1382341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon.
    Ito M; Baba M; Shigeta S; De Clercq E; Walker RT; Tanaka H; Miyasaka T
    Antiviral Res; 1991 May; 15(4):323-30. PubMed ID: 1683214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
    Johnson VA; Barlow MA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies with the non-nucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152E.
    Althaus IW; Chou JJ; Gonzales AJ; Deibel MR; Chou KC; Kezdy FJ; Romero DL; Thomas RC; Aristoff PA; Tarpley WG
    Biochem Pharmacol; 1994 Jun; 47(11):2017-28. PubMed ID: 7516658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.